AXS Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155K Sell
400
-100
-20% -$37.1K 0.04% 125
2026
Q1
$146K Sell
500
-99
-17% -$32.5K 0.06% 127
2025
Q4
$210K Sell
599
-79
-12% -$26.7K 0.07% 128
2025
Q3
$219K Buy
+678
New +$211K 0.07% 128
2025
Q2
Sell
-681
Closed -$296K 171
2025
Q1
$296K Buy
681
+51
+8% +$20.5K 0.08% 196
2024
Q4
$232K Sell
630
-70
-10% -$29.3K 0.06% 214
2024
Q3
$364K Buy
700
+11
+2% +$5.88K 0.1% 208
2024
Q2
$373K Sell
689
-143
-17% -$75.6K 0.1% 206
2024
Q1
$431K Buy
832
+108
+15% +$53.7K 0.1% 230
2023
Q4
$341K Sell
724
-51
-7% -$23.6K 0.08% 250
2023
Q3
$337K Sell
775
-140
-15% -$63.5K 0.09% 234
2023
Q2
$407K Sell
915
-37
-4% -$17.1K 0.11% 225
2023
Q1
$438K Sell
952
-119
-11% -$56.6K 0.14% 182
2022
Q4
$549K Buy
1,071
+1
+0.1% +$508 0.2% 159
2022
Q3
$486K Sell
1,070
-224
-17% -$107K 0.19% 164
2022
Q2
$624K Sell
1,294
-291
-18% -$144K 0.22% 159
2022
Q1
$779K Sell
1,585
-454
-22% -$208K 0.31% 70
2021
Q4
$945K Buy
+2,039
New +$858K 0.22% 80
2021
Q3
Sell
-2,398
Closed -$916K 143
2021
Q2
$916K Sell
2,398
-657
-22% -$251K 0.28% 81
2021
Q1
$1.1M Buy
+3,055
New +$982K 0.39% 64

Other funds holding ELV

AXS Investments's ELV Position: Q2 2026 in Review

AXS Investments reduced its Elevance Health (ELV) stake by 20% in Q2 2026, selling an estimated $37.1K and leaving 400 shares worth $155K. The position accounts for 0.04% of the portfolio, ranked #125.

AXS Investments first reported a position in ELV in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.1M in Q1 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AXS Investments held 400 shares of Elevance Health worth $155K as of Q2 2026.
  • AXS Investments sold 100 Elevance Health shares in Q2 2026, an estimated $37.1K.
  • Elevance Health made up 0.04% of AXS Investments's portfolio in Q2 2026, its #125 holding.
  • AXS Investments first reported a position in Elevance Health in Q1 2021 and has held it in 20 quarters since.
  • AXS Investments's Elevance Health position peaked at $1.1M in Q1 2021.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.